ARIALYS
DEAD

Serial Number

97153379

Owner

Arialys Therapeutics, Inc.

Attorney

Alyssa M. Worsham

Filing Date

Dec 2, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ARIALYS Trademark

Serial Number: 97153379

ARIALYS is a trademark filed by Arialys Therapeutics, Inc. on December 2, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Arialys Therapeutics, Inc. (2 trademarks)

11099 North Torrey Pines Rd., Suite #290
La Jolla, CA 92037

Entity Type: 03

Trademark Details

Filing Date

December 2, 2021

Registration Date

Not Registered

Published for Opposition

October 25, 2022

Goods & Services

Allergy relief medication; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; antibiotics; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating asthma; pharmaceutical agents for epidermis; anesthetics for surgical use; cardiovascular pharmaceutical preparations; pharmaceutical products for the treatment of infectious diseases; pharmaceutical agents affecting sensory organs; antiallergic medicines; pharmaceutical preparations for peripheral nervous system; medicines for dental purposes; pharmaceutical agents affecting digestive organs; eye drops; ear drops; nasal sprays for medical purposes; medical preparation for slimming purposes; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in dermatology; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; tumor suppressing agents; pain relief medication; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for treating hypertension; anaesthetics; alcohol for pharmaceutical purposes; diagnostic reagents for medical use; capsules sold empty for pharmaceuticals; dietetic preparations adapted for medical purposes; adhesive plasters for medical purposes; medical dressings; teeth filling material; lacteal flour for babies; nutritional supplements; baby food; dietary supplements for animals; semen for artificial insemination

Research in the field of pharmaceuticals; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; research on the subject of pharmaceuticals; drug discovery services; pharmaceutical research services; development of pharmaceutical preparations and medicines; medical research; chemical research; chemical analysis; bacteriological research; biological research; conducting clinical trials for others; scientific research; scientific laboratory services

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 26, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 26, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 8, 2025 EXRA
SOU EXTENSION 5 GRANTED
Jul 7, 2025 EX5G
SOU TEAS EXTENSION RECEIVED
Jun 18, 2025 EEXT
SOU EXTENSION 5 FILED
Jun 17, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2024 EXRA
SOU EXTENSION 4 GRANTED
Dec 17, 2024 EX4G
SOU EXTENSION 4 FILED
Dec 5, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 5, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 22, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 22, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 22, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 22, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 29, 2024 EXRA
SOU EXTENSION 3 GRANTED
May 28, 2024 EX3G
SOU EXTENSION 3 FILED
May 28, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
May 28, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 14, 2024 EXRA
SOU EXTENSION 2 GRANTED
Feb 13, 2024 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 13, 2024 AITU
NOTICE OF REVIVAL - E-MAILED
Dec 22, 2023 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Dec 22, 2023 TPEX
NOTICE OF REVIVAL - E-MAILED
Dec 22, 2023 NREV
PETITION TO REVIVE-GRANTED
Dec 22, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Dec 22, 2023 PROA
SOU EXTENSION 2 FILED
Dec 20, 2023 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 14, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 12, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 12, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 12, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 20, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 20, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 20, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 20, 2022 CNEA
ASSIGNED TO EXAMINER
Sep 12, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2021 NWOS
NEW APPLICATION ENTERED
Dec 6, 2021 NWAP